At least 9 senators reported stock purchases or gross sales final yr involving firms in industries overseen by the committees they serve on. These transactions fear authorities watchdog teams, as a bipartisan effort to ban the observe has faltered on Capitol Hill.
Most of the 9 senators who invested in shares that overlap with their committee assignments over the past yr have complete monetary portfolios, not all of which elevate potential conflict-of-interest points, in keeping with a database of congressional monetary filings compiled by Capitol Trades and reviewed by NCS. But the greater than a dozen trades from this small group of well-connected senators present a window into why the phenomenon of lawmaker stock-trading has led to public outrage – and a serious push to ban the observe.
When disclosing stock trades, lawmakers have to incorporate the proprietor of the stock. These are senators who listed themselves as homeowners of stock in industries that their committees regulate. In the House, lawmakers have an choice to not disclose the proprietor of the stock.
“It’s all extremely troubling,” mentioned Dylan Hedtler-Gaudette, performing vp of the Project on Government Oversight, a nonpartisan watchdog group. “It’s a bipartisan problem. Republicans and Democrats are guilty of this, pretty evenly across the board. There’s an institutional rot at the core of this.”
The trades made by the senators are authorized, and the lawmakers who disclosed these trades deny that they’ve any private management over how their stock portfolios are invested.
But polls have constantly discovered widespread assist for banning members of Congress from proudly owning shares. The problem has acquired nationwide consideration — and alarmed nonpartisan ethics consultants — due to suspiciously timed sales at the beginning of the Covid-19 pandemic, and from lively buying and selling by high-profile members like former longtime House Speaker Nancy Pelosi. And through the years, dozens of lawmakers have disclosed stock trades in firms which are influenced by their committee work.
At least one Democrat and one Republican who’ve supported congressional stock-trading bans are among the many senators who disclosed trades in current months involving firms that cross their committee work.
That Republican, Sen. Ashley Moody, in current weeks introduced a bipartisan invoice to ban lawmaker stock-trading.
Yet, the Florida Republican who sits on the Senate’s well being committee, invested in 5 well being care firms, in keeping with federal records. Those embody shopping for between $100,000 and $250,000 within the pharmaceutical big Eli Lilly final March.
Eli Lilly spent thousands and thousands of {dollars} lobbying Congress final yr. The panel’s GOP chair launched a report about federal drug-pricing that relied on testimony from Eli Lilly, and Senate Democrats are scrutinizing the corporate’s relationship with telehealth corporations.
Moody’s workplace mentioned in an announcement to NCS that the Florida Republican has by no means permitted or initiated a stock commerce.
“When she was appointed to the Senate at the end of January 2025, she was a part of an extended family investment partnership where a partner independently made investment decisions in consultation with a third-party financial advisor, and with no input from the Senator,” her workplace mentioned within the assertion.
Since then, Moody’s workplace says the senator “immediately” took steps to withdraw from the partnership and has not traded shares since April 2025. “As a sign of this commitment, Senator Moody introduced legislation to restore trust in Congress and ensure there is no appearance of impropriety as it relates to members trading individual stocks,” the assertion reads.
Democratic Sen. John Hickenlooper additionally invested in an organization that overlaps with his committee assignments, regardless of lately changing into a co-sponsor on laws that may put restrictions on lawmaker stock-trading exercise.
In September 2025, Hickenlooper invested between $100,000 and $250,000 right into a cybersecurity firm referred to as Palo Alto Networks whereas serving on the Senate Commerce Committee, information present.
The General Services Administration announced a brand new partnership in December letting federal companies purchase Palo Alto Network merchandise at reductions as much as 60%. Experts instructed NCS this raised purple flags as a result of the contracts may benefit Hickenlooper, whose committee does oversight of federal contracts.
In response, a Hickenlooper spokesperson instructed NCS that the senator “does not personally trade stocks. His stocks are already in a blind trust and have been since he was mayor of Denver in 2003. All decisions are made by a manager without the senator’s prior knowledge or input.” The spokesperson additionally pointed to Hickenlooper’s co-sponsoring of laws that may pressure all members of Congress to put their shares into a professional blind belief in order that they will’t use insider info to tell their portfolio choices and switch a revenue.
GOP Sen. Markwayne Mullin, who can be on the Senate well being panel, sold stock in January 2025 by a joint account with his spouse in Abbott Laboratories, a medical gadgets and well being care firm. Abbott listed the Senate as a part of its lobbying efforts one month earlier than Mullin’s commerce.
At that point, Abbott was within the midst of a slew of yearslong lawsuits over contaminated baby formula, together with one case that led to a $495 million damages award.
But Mullin’s workplace maintains that the senator isn’t making the trades directly. “Senator Mullin uses an independent, third-party operator firm that manages all stock portfolio investments on his behalf,” a spokesperson mentioned. “He does not conduct nor inform trades. This independent firm reports bi-weekly with Senate Ethics to ensure compliance with federal law.”
And Democratic Sen. Sheldon Whitehouse, who sits on the Senate Finance Committee, disclosed between $1,000 and $15,000 of stock in UnitedHealth Company in November 2025 in an account he owns.
Still, a Whitehouse spokesperson, Meaghan McCabe, distanced the Rhode Island Democrat from the commerce. “The Senator does not trade stocks, and his account manager is contractually required to act independently without any input from the Senator. He supports a ban on members trading stocks and is reviewing the various proposals,” Whitehouse spokesperson Meaghan McCabe instructed NCS.
Records show that GOP Sen. Jerry Moran purchased stock in Alphabet Inc, the dad or mum firm of Google, on the same day he participated within the Senate Commerce Committee’s listening to to debate the way forward for synthetic intelligence.
Executives from main know-how firms like OpenAI and Microsoft testified as witnesses on the listening to, although nobody from Alphabet or Google.
When Moran purchased the shares in May, the Senate was actively contemplating deregulating AI, which might profit firms like Alphabet. After a serious public backlash, the supply making a moratorium on AI rules was stripped out of the ultimate model of Trump’s so-called “big, beautiful bill.”
“Sen. Moran’s financial investments are managed independently by a broker, who has full discretion over Sen. Moran’s investment accounts,” a Moran spokesperson instructed NCS.
Experts on congressional stock-trading instructed NCS they weren’t glad with the senators’ explanations.
Emma Lydon, managing director of progressive lobbying group P Street, mentioned “merely the perception” of potential insider coaching “erodes trust in our democracy.” She famous that a number of studies have found that, on common, lawmakers who commerce shares typically outperform the S&P.
“When caught making eyebrow-raising trades, members of Congress often claim ignorance, saying the trades were done without their knowledge by independent financial brokers,” Lydon mentioned. “Unfortunately for the American people, it’s impossible to know whether they’re telling the truth.”
Kedric Payne, who runs the ethics program on the Campaign Legal Center, a left-leaning advocacy group, mentioned conflict-of-interest issues persist due to the opaqueness of the present system, the place lawmakers can legally commerce shares in firms whereas deciding how these industries are regulated.
“The public will always question whether any decision made by that member on that committee was really focused on what’s best for the constituents, or what’s best for their personal financial gain,” Payne mentioned.
Payne, who labored within the Office of Congressional Ethics when the stock-trading disclosure regulation was passed in 2012, added that, “it is nearly impossible to prove that they use insider Information, but trades like these look like a conflict of interest – and therefore the harm to the public interest remains.”
While some payments are lively within the Senate, a House-negotiated compromise to ban future stock-trading by members of Congress and pressure them to divest all present holdings appeared to choose up probably the most momentum of the proposals on the Hill final yr.
At one level, a small group of House Republicans had been making an attempt to avoid their celebration’s management to carry that bipartisan invoice to the ground. But that maneuver remains to be far away from clinching the signatures wanted, and leaders from each events have lately taken steps to undermine that bipartisan proposal, stakeholders say.
That invoice, the Restore Trust in Congress Act, was “the product of painstaking negotiations,” Hedtler-Gaudette mentioned. Its 127 cosponsors embody conservative Republicans like Rep. Chip Roy and Rep. Nancy Mace, and progressive Democrats like Rep. Alexandria Ocasio-Cortez and Rep. Ilhan Omar.
In December, Democratic House Minority Leader Hakeem Jeffries rolled out a separate congressional stock ban proposal that may additionally apply to Trump and Vice President JD Vance — a nonstarter amongst most Republican lawmakers. This transfer alarmed ethics consultants and liberal activists who supported that coverage in precept, however noticed the brand new invoice as an try and tank the extra viable bipartisan invoice.
“The Jeffries bill was a problem because it got in the way of the bipartisan consensus bill that would really solve the issue,” Payne mentioned. “So out of nowhere, you had this obstacle, which was not needed, coming from Jeffries.”
House Speaker Mike Johnson, who has been pressured by fellow Republicans to permit a vote on the bipartisan invoice, made his transfer final month. He backed a watered-down GOP proposal that may let members preserve their present stock portfolios, however it might require a seven-day discover earlier than a stock sale and would stop lawmakers and their households from making new purchases. Democrats and a few nonpartisan ethics consultants say that may make the issue worse.
“It has so many loopholes that it’s a paper tiger,” Hedtler-Gaudette mentioned. “They can now rally around this, and claim that they did something. But it’s a big fat nothing-burger, in terms of solving the problem.”
The House Administration Committee superior that invoice earlier this month with solely GOP assist, teeing up a probable ground vote.